Back to Search
Start Over
4-Aminopyrazolopyrimidine scaffold and its deformation in the design of tyrosine and serine/threonine kinase inhibitors in medicinal chemistry
- Source :
- MedChemComm; 2022, Vol. 13 Issue: 9 p1008-1028, 21p
- Publication Year :
- 2022
-
Abstract
- The 4-Aminopyrazolopyrimidine scaffold has been an interesting pharmacophore since the disclosure of the intimate connection between small-molecule inhibitors and the treatment of diseases. Modification of the 4-aminopyrazolopyrimidine scaffold according to different targets, especially tyrosine kinase and serine/threonine kinase, has resulted in a variety of small-molecule inhibitors. Kinase inhibitors with 4-aminopyrazolopyrimidine derivatives as scaffolds have been widely applied in the treatment of diseases. In this article, we summarized the reports on 4-aminopyrazolopyrimidine as well as its deformation and the application of its derivatives in designing small-molecule inhibitors and the treatment of diseases.
Details
- Language :
- English
- ISSN :
- 20402503 and 20402511
- Volume :
- 13
- Issue :
- 9
- Database :
- Supplemental Index
- Journal :
- MedChemComm
- Publication Type :
- Periodical
- Accession number :
- ejs60846730
- Full Text :
- https://doi.org/10.1039/d2md00139j